United States · FDA National Drug Code directory
Sulfasalazine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62135-960_ef9f56ad-c921-6fe7-e053-2a95a90a85af
- Product NDC
- 62135-960
- Form
- TABLET
- Composition / generic term
- Sulfasalazine
- Labeler
- Chartwell RX, LLC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 19731112
- Source listing expiry
- 20261231
Source-listed ingredients
- SULFASALAZINE — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (62135-960-01) · 62135-960-01
- 500 TABLET in 1 BOTTLE (62135-960-05) · 62135-960-05
- 1000 TABLET in 1 BOTTLE (62135-960-10) · 62135-960-10
- 300 TABLET in 1 BOTTLE (62135-960-31) · 62135-960-31
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →